Terms: = Germ cell tumor AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
44 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.
Gimple RC; Zhang G; Wang S; Huang T; Lee J; Taori S; Lv D; Dixit D; Halbert ME; Morton AR; Kidwell RL; Dong Z; Prager BC; Kim LJ; Qiu Z; Zhao L; Xie Q; Wu Q; Agnihotri S; Rich JN
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795488
[TBL] [Abstract] [Full Text] [Related]
3. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma.
Håvik AL; Bruland O; Miletic H; Poulsgaard L; Scheie D; Fugleholm K; Lund-Johansen M; Knappskog PM
Acta Neurochir (Wien); 2022 Feb; 164(2):343-352. PubMed ID: 34816314
[TBL] [Abstract] [Full Text] [Related]
4. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
[TBL] [Abstract] [Full Text] [Related]
5. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal tumors.
Ibrahim A; Chopra S
Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
[TBL] [Abstract] [Full Text] [Related]
6. Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours.
Sun C; Zhao Y; Shi J; Zhang J; Yuan Y; Gu Y; Zhang F; Gao X; Wang C; Wang Y; Wang Z; Hu P; Qin J; Xiao L; Chang T; Wang L; Xi Y; Yin H; Chen H; Zhang L; Cheng G; Lin J; Zhang M; Li Z; Ye J
J Neurooncol; 2019 Jun; 143(2):187-196. PubMed ID: 31004262
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma.
Cardona AF; Rojas L; Wills B; Ruiz-Patiño A; Abril L; Hakim F; Jiménez E; Useche N; Bermúdez S; Mejía JA; Ramón JF; Carranza H; Vargas C; Otero J; Archila P; Rodríguez J; Rodríguez J; Behaine J; González D; Jacobo J; Cifuentes H; Feo O; Penagos P; Pineda D; Ricaurte L; Pino LE; Vargas C; Marquez JC; Mantilla MI; Ortiz LD; Balaña C; Rosell R; Zatarain-Barrón ZL; Arrieta O
Clin Transl Oncol; 2019 Oct; 21(10):1364-1373. PubMed ID: 30798512
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with VEGF and pdgfr.
Watanabe S; Suzuki T; Kondo Y; Naoe A; Uga N; Yasui T; Hara F; Tsuchiya T
Minerva Pediatr (Torino); 2023 Aug; 75(4):561-566. PubMed ID: 30605998
[TBL] [Abstract] [Full Text] [Related]
9. The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.
Ehrhardt M; Craveiro RB; Velz J; Olschewski M; Casati A; Schönberger S; Pietsch T; Dilloo D
J Cell Mol Med; 2018 Apr; 22(4):2153-2161. PubMed ID: 29377550
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of clinical factors and pdgfr-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting pdgfrb.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract] [Full Text] [Related]
12. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract] [Full Text] [Related]
13. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract] [Full Text] [Related]
14. Characterizing and targeting pdgfrA alterations in pediatric high-grade glioma.
Koschmann C; Zamler D; MacKay A; Robinson D; Wu YM; Doherty R; Marini B; Tran D; Garton H; Muraszko K; Robertson P; Leonard M; Zhao L; Bixby D; Peterson L; Camelo-Piragua S; Jones C; Mody R; Lowenstein PR; Castro MG
Oncotarget; 2016 Oct; 7(40):65696-65706. PubMed ID: 27582545
[TBL] [Abstract] [Full Text] [Related]
15. Differences in Dural Penetration of Clival Chordomas Are Associated with Different prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.
Zhai Y; Bai J; Wang S; Du J; Wang J; Li C; Gui S; Zhang Y
World Neurosurg; 2017 Feb; 98():288-295. PubMed ID: 27506406
[TBL] [Abstract] [Full Text] [Related]
16. L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression.
Rached J; Nasr Z; Abdallah J; Abou-Antoun T
Int J Oncol; 2016 Oct; 49(4):1722-30. PubMed ID: 27432152
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of lenvatinib in treating thyroid cancer.
Krajewska J; Kukulska A; Jarzab B
Expert Opin Pharmacother; 2016 Aug; 17(12):1683-91. PubMed ID: 27398740
[TBL] [Abstract] [Full Text] [Related]
18. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
[TBL] [Abstract] [Full Text] [Related]
19. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical Analysis of pdgfr-α, pdgfr-β and c-Abl in Retinoblastoma: Potential Therapeutic Targets.
Sanft DM; Worme MD; Rielo de Moura L; Zoroquiain P; Fernandes BF; Antecka E; Burnier MN
Ophthalmic Res; 2016; 55(3):159-62. PubMed ID: 26761215
[TBL] [Abstract] [Full Text] [Related]
[Next]
